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 Abstract. Background: With the increasing popularity of
skin–sparing mastectomy techniques, implant-based breast
reconstruction and use of perioperative radiation therapy, there
is a growing need to scrutinize the effects they have on breast
reconstruction. This study examined the effect of radiation on
implant-based breast reconstruction in patients who had skin-
sparing or conventional mastectomies in terms of complication,
reoperation, and capsular contracture rates. Patients and
Methods: A retrospective review of 227 implant-based breast
reconstructions in 132 mastectomy patients by a single surgeon
was undertaken. All cases occurred over a four-year period
(2006-2009) at a single institution. Complication, re-operation,
and capsular contracture rates were tabulated against
immediate and delayed reconstruction, skin-sparing and
conventional mastectomy implant-based reconstruction, and
irradiated and non-irradiated groups. Chi-square test was
performed for statistical analysis. Results: The overall
complication and reoperation rates of 15% and 10% in these
227 reconstructions compare favorably to reviewed series.
Delayed reconstruction, skin-sparing mastectomy and
irradiation were all associated with a significantly increased
rate of re-operation, but not to an increase in complication or
capsular contracture rates. Conclusion: The results of this study
were more favourable than those of similar studies reported in
the current literature, suggesting an increased role for implant-
based reconstruction in the setting of adjuvant radiotherapy for
patients that undergo skin-sparing mastectomy.
Undergoing mastectomy has implications for the
psychosocial well-being of the patient and every attempt
should be made to reconstruct the breast in suitable patients
(1). Skin-sparing mastectomy (SSM) is one of the techniques
developed to improve the aesthetic result of breast
reconstruction. The concept of preoperative plastic surgery
planning together with SSM was first brought to the
forefront by Toth et al. in 1991 (2). It involves the
preservation of a native skin envelope with the removal of
the breast, nipple-areolar complex, biopsy scars and skin
overlying any superficial tumours (2). The ideal SSM would
have a skin flap devoid of all breast tissue but having an
adequate blood supply to prevent flap necrosis and delayed
wound healing. It is believed that the preservation of the skin
architecture and intact infra-mammary fold, allows for
immediate breast reconstruction, thereby reducing the
number of reoperations and improving the cosmetic
appearance of the breast. 
For many years, the expander/implant option was not
available as a reconstructive option post mastectomy and
autologous tissue was the mainstay of treatment. Various
studies also suggested that tissue expansion was associated
with a significantly higher complication rate (3-6). In fact,
in a study by Kroll and Baldwin, in 325 post-mastectomy
reconstruction patients reported, the failure rate for tissue
expansion was as high as 21% whilst the failure rate for
transverse rectus abdominis myocutaneous (TRAM) flaps
was only 3% (4). Other studies have been more favorable
towards implants, with one study by Rosen and colleagues
finding that the complication rates were similar between
TRAM and tissue expander/implant reconstruction for breast
reconstruction (7), a finding echoed in other series (8, 9).
While there are studies which have demonstrated the
efficacy of SSM and autologous reconstruction (5), SSM
with expander/implant reconstruction has been sparcely
evaluated in the literature. A PubMed search of ‘skin sparing
mastectomy’ and ‘tissue expansion’ or ‘implant’ revealed 30
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original articles, with the first articles of any relevance being
published within the last 10 years. 
This study explores the outcome of breast implants
following conservative mastectomy and SSM. It also
examines the complication and reoperation rates in patients
who underwent delayed versus immediate reconstruction, as
well as patients who did and did not undergo radiation
therapy. The main hypothesis is that that there is no difference
in outcome between patients undergoing SSM versus
conventional mastectomy. The secondary hypotheses include
that there is no difference in complication rate in patients
undergoing delayed versus immediate reconstruction, but an
increased complication rate in patients who undergo
radiotherapy of the affected breast and axilla.
Patients and Methods
A retrospective review was performed of 132 patients undergoing
227 implant-based breast reconstructions over a four year period at
a single institution, by a single surgeon (RK). Follow-up ranged
from 12 to 36 months postoperation. All patients had reconstructions
with either Mentor (Irving Texas,  USA) or Inamed/Allergan (Irvine
California, USA) expanders (subpectoral) together with either SSM
or conventional mastectomy (see Figure 1). The creation of a sling
was performed with Alloderm (LifeCell, Branchburg New Jersey,
USA), FlexHD (Ethicon, Somerville New Jersey, USA), Neoform
(Mentor, Irving Texas, USA) or Strattice (LifeCell, Branchburg,
New Jersey,  USA). No attempt was made to standardize initial fill
volumes, time to full expansion, or final volumes achieved
Data collected included type of surgery (immediate versus
delayed, SSM versus conventional mastectomy), history of
radiotherapy treatment and complications. Complications include
reoperation, capsular contracture, infection, seroma formation, post-
operative haematoma, implant exposure and delayed wound healing.
The modified Baker classification of capsular contracture was used
(10). All personal identifiers were removed from the data as
stipulated by the Human Subjects Review Committee. Results were
recorded and tabulated using Microsoft Access (Microsoft
Corporation, Redmond Washington, USA). Chi-square tests were
performed on the data, and p-values were used to evaluate the data
for statistical significance.
Results
A total of 132 patients received 227 mastectomies, of whom
64% (145 patients) had conventional mastectomy skin
envelope excisions, 33% (75 patients) were SSMs, and 3% (7
patients) were of Wise pattern excisions. The average age of
patients was 52 years with the following ethnic breakdown:
84% White, 5% African-American, 5% Hispanic, 1% Asian
and 5% other. 2% were current smokers, 18% had a history of
smoking, and 80% were nonsmokers. A total of 8% of the
patients were diabetic. With regard to radiation exposure in
this study, 12% had a remote history (>1 year prior to
surgery), 9% had immediate preoperative radiation, and 15%
had postoperative radiation.
The overall complication and re-operation rates were 15%
and 10% respectively (Tables I-III). Of the patients who had
infected implants, half were managed conservatively with
antibiotics whilst the remaining half necessitated surgical
removal of the implants. A total of 6/8 implant exposures
were treated with removal of implant, whilst the remaining
25% received irrigation and closure. Two out of the three
hematomas required surgical drainage.
SSM vs. conventional mastectomy. Overall, the SSM group
had a lower complication rate (12% vs. 18%) but a greater
reoperation and capsular contracture rate than the
conventional mastectomy group (Table I). Of these, only the
reoperation rate was statistically significant (p<0.01).
Immediate vs. delayed. Delayed breast reconstructions were
associated with a significantly greater number of
reoperations (p<0.0001) than immediate reconstructions, but
the overall complication rates were similar (Table II). The
immediate group had a higher rate of capsular contracture
(5% vs. 0%), although this difference was not statistically
significant (p=0.21).
Influence of radiation. The irradiated group had higher rates
of complications and re-operations (Table III), but only the
rate of reoperation between the two proved significant
statistically (p=0.02). Capsular contraction was similar in the
two groups.
Discussion
The field of implant-based reconstruction is constantly
undergoing changes. These changes include the advent of
dual chambers, anatomic and cohesive variations, texture
modifications, and ever-evolving proprietary manipulation.
As a result, implant-based reconstruction data are difficult to
standardize over any prolonged period of time. Similarly,
size of implant, initial volume, final volume, and rapidity of
expansion are tailored to meet patient goals and expectations
and can never be fully standardized. The development of
skin-sparing and, more recently, nipple-sparing techniques
also adds a distinct element to the gamut of variability.
The overall complication rate of our implant-based
reconstruction was 15%, with a reoperation rate of 10%. This
is lower than the percentage reported by Rosen et al. in 1990,
who had a complication rate of 23% in their tissue expander
group and 24% in their TRAM flap group (7). It is also much
lower than the rate reported by a large study of 165
immediate reconstructions in 1986 by Bailey et al., who had
a 22% implant and 15% expander loss, and an overall
complication rate of 57% (11). This may reflect not only
differences in the implants and expanders themselves, but also
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a learning curve where it is presumed that over the last 30
years, surgical techniques have improved over time (12, 13).
Breast reconstruction may be performed immediately
postmastectomy or delayed for up to years following the
initial mastectomy. Immediate breast reconstruction is often
recommended for psychosocial benefits, but obviously this
needs to be weighed against the judgment of the patient and
surgeon, and individual oncologic needs (including further
operation and adjuvant radiotherapy) (1). This study has
demonstrated that not only is implant-based reconstruction
associated with a low complication rate, but immediate
reconstruction is also associated with a statistically
significant lower reoperation rate.
There are two major concerns regarding implant
reconstruction following SSM. The first is that most breast
reconstructions occur in the anterior chest skin and therefore
SSM may increase the risk of recurrence (1). The breast
Hughes et al: Radiotherapy in Implant-based Breast Reconstruction
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Figure 1. A: smooth saline implant; B: smooth, cohesive silicone gel implant; C: saline tissue expander. Images supplied by Mentor (California,
USA). Reproduced with permission from Rozen et al. (22).





SSM 8 66 0.7539 0.39
Conventional 23 130
Reoperation None
SSM 18 56 6.6772 <0.01
Conventional 17 136
Capsular contraction None
SSM 6 68 2.534 0.11
Conventional 5 148





Immediate 30 167 0.4442 0.5
Delayed 6 24
Reoperation None
Immediate 16 181 24.4675 <0.0001
Delayed 12 18
Capsular contraction None
Immediate 10 187 1.593 0.21
Delayed 0 30




Radiotherapy 14 69 1.5212 0.22
No radiotherapy 16 128
Reoperation None
Radiotherapy 16 67 5.8316 0.02
No radiotherapy 12 132
Capsular contraction None
Radiotherapy 2 81 0.028 0.87
No radiotherapy 4 140
surgeon must balance the risk of skin necrosis in the residual
skin flap to the risk of recurrence if breast tissue is left behind
in the SSM flap. A multitude of studies has demonstrated that
there are no differences in local recurrence rate and overall
survival between mastectomy and reconstructed groups (1).
Secondly, studies have shown that there is a severe
complication rate of approximately 20% in patients who
undergo immediate implants following SSM (14-16). Another
study has suggested that careful selection of patients could
result in a complication rate as low as 5% (17). Our
complication rate was at the lower end of that reported in the
literature, again perhaps reflecting the learning curve in the
skin-sparing paradigm.
Overgaard et al.’s landmark trials in 1997 resulted in
radiation therapy becoming increasingly used as adjuvant
therapy (18), shown to reduce the local recurrence rate, prolong
disease-free survival and increase the overall survival rate (1).
One would expect breast irradiation to be associated with
higher postoperative complication due to radiation associated
damage to surrounding tissues (1). Some researchers have
classed patients who have had irradiation to be similar to heavy
smokers and have recommended SSM to be avoided in such
patients (14). Other studies have shown that radiation therapy is
associated with an unacceptably high rate of capsular
contracture and rupture of the implant envelope or capsule (1,
19, 20). A study by Spear and Onweyu in 2000, comprising of
40 consecutive patients undergoing staged expander/implant
placement and radiotherapy during a seven year period,
demonstrated a capsular contracture rate of 21% in the
irradiated group vs. 0% in the control group(21). However, our
study has not shown this. One could argue that as capsular
contracture develops over months to years, this study does not
have the long-term follow-up to evaluate the overall contracture
rate. Spear and Onweyu’s study also reported complications to
be more common in the irradiated group (36%) than in the
control group (7%) (21). The infection rate was also higher at
4% in the irradiated group and 0% in the control group (21).
Finally, 32% of irradiated breasts with implants ultimately
needed the addition of a flap (21). Our study has demonstrated
somewhat different results, with irradiated breasts having a
statistically higher reoperation rate, but a similar complication
rate as non-irradiated breasts. This could also be due to
improvement in the targeting of radiotherapy in order to limit
damage to surrounding tissue, improved surgical techniques, or
better quality of implants.
A word of clarification should be entered on the nature of
the capsular contracture. None of the patients were observed
to have any greater than Baker grade II capsular contracture,
and the overwhelming majority were classified as grade I.
An additional group of patients remained in relatively early
follow-up period after implant placement (<6 months). As
such, capsular contracture rates from the latter group were
excluded from all calculations.
Conclusion
The goal of the current study was to determine complication,
reoperation, and capsular contracture rates in implant-based
reconstruction after SSM and adjuvant radiotherapy. While
the study showed a trend toward SSM being associated with
lower complication rates compared to conventional
mastectomy, the study did not reveal an effect on the
reoperation rate or rate of capsular contracture. Radiation
exposure negatively impacted reoperation rates but, oddly,
did not lead to any increase in capsular contracture or overall
complication rates. The complication, reoperation and
capsular contracture rates are lower than what has been
traditionally reported in literature, and may reflect the
increased surgical expertise, more targeted radiation therapy
and improved implants being used for the patients.
Immediate reconstruction with implants in patients who have
undergone SSM, even in irradiated tissue, appears to be a
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